Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Anthem Biosciences Ltd

NSE: ANTHEM · BSE: 544449 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹873.60
Market cap: ₹49,201 Cr
Revenue (annual): ₹2,124 Cr
Net profit (annual): ₹591.8 Cr
P/E (TTM): 85.4×Sector 50.4×
Promoter holding: 71.42%-3.26% QoQ
FII holding: 2.57%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 2 Other Announcement 1 Legal & Regulatory 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

21 Jul 2026 16:27 IST NSE

Financial Results

Anthem Biosciences Q1 FY27 Results: Net Profit ₹119.9 Cr, Down 11.7% YoY

Anthem Biosciences Ltd reported revenue from operations of ₹418.2 Cr (-22.6% YoY) and net profit of ₹119.9 Cr (-11.7% YoY) for Q1 FY27.

Key figure: Net profit ₹119.9 Cr · -11.7% YoY

Open full results → Read the filing ↗

19 May 2026 18:53 IST NSE

Financial ResultsAlfa Alert

Anthem Biosciences Q4 FY26 Results: Net Profit ₹189.8 Cr, Up 129.8% YoY

Anthem Biosciences Ltd reported revenue from operations of ₹610.9 Cr (+26.4% YoY) and net profit of ₹189.8 Cr (+129.8% YoY) for Q4 FY26.

Key figure: Net profit ₹189.8 Cr · +129.8% YoY

Open full results → Read the filing ↗